Resource Library

Whitepapers

Reducing ADC timelines with integrated development and manufacturing services

Whitepapers - Reducing ADC timelines with integrated development and manufacturing services
 

Antibody-Drug Conjugates (ADCs) consist of different elements requiring specialized capabilities during the manufacturing process. Given the complexity of their development and manufacturing, accelerating timelines becomes a pivotal success factor for the ADC market.

 

In this whitepaper, Thomas Rohrer, Senior Director of Technical Support Bioconjugates, delves into how integrating development and production activities within a single outsourcing partner can dramatically streamline ADC development timelines and mitigate risks.

Whitepapers - Reducing ADC timelines with integrated development and manufacturing services
 

Antibody-Drug Conjugates (ADCs) consist of different elements requiring specialized capabilities during the manufacturing process. Given the complexity of their development and manufacturing, accelerating timelines becomes a pivotal success factor for the ADC market.

 

In this whitepaper, Thomas Rohrer, Senior Director of Technical Support Bioconjugates, delves into how integrating development and production activities within a single outsourcing partner can dramatically streamline ADC development timelines and mitigate risks. 

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION